Mitera Management announced it raised $50,000 in an initial filing from an offering of $550,000

Company

Location

About

Mitera is a telehealth company focused on reproductive health. We help inform and educate our patients about their pregnancy-related risks and options through at-home genetic testing kits, empowering them along their family-forming journey. We are the only solution that combines patient education, physician genetic test orders, at-home genetic test kits and follow-up telehealth consultations in the reproductive space. At the same time, we keep our clients' primary providers in the loop and provide referrals for follow-up care, if needed. Mitera is now offering the first at-home non-invasive prenatal test (NIPT) known as Peaches&Me and an at-home expanded carrier screening (ECS) test called 23Pears. Both tests can be ordered by patients themselves directly from our website. Peaches&Me is the first at-home NIPT in the market.